biospecimen__admin__batch_number	384.50.0
biospecimen__admin__bcr	Nationwide Children's Hospital
biospecimen__admin__day_of_dcc_upload	1
biospecimen__admin__disease_code	LIHC
biospecimen__admin__file_uuid	8FA36B3E-2F95-41EE-8EB6-F6914E57951A
biospecimen__admin__month_of_dcc_upload	7
biospecimen__admin__year_of_dcc_upload	2016
biospecimen__bio__bcr_analyte_barcode	TCGA-G3-AAV5-01A-11R
biospecimen__bio__bcr_portion_barcode	TCGA-G3-AAV5-01A-11
biospecimen__bio__bcr_sample_barcode	TCGA-G3-AAV5-01A
biospecimen__bio__biospecimen_barcode_bottom	0164104851
biospecimen__bio__day_of_creation	03
biospecimen__bio__day_of_shipment	26
biospecimen__bio__days_to_index	0
biospecimen__bio__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen__bio__is_derived_from_ffpe	NO
biospecimen__bio__month_of_creation	02
biospecimen__bio__month_of_shipment	02
biospecimen__bio__pathology_report_file_name	TCGA-G3-AAV5.A578503A-47F1-4DD4-B3E8-C1642EF89190.pdf
biospecimen__bio__plate_column	4
biospecimen__bio__plate_id	A37K
biospecimen__bio__plate_row	D
biospecimen__bio__quantity	2.34
biospecimen__bio__subportion_sequence	1
biospecimen__bio__vial_number	A
biospecimen__bio__volume	13.00
biospecimen__bio__year_of_creation	2014
biospecimen__bio__year_of_shipment	2014
biospecimen__shared__bcr_patient_barcode	TCGA-G3-AAV5
biospecimen__shared__patient_id	AAV5
clinical__ablation__ablation_performed_indicator	NO
clinical__ablation__bcr_ablation_barcode	TCGA-G3-AAV5-A62435
clinical__ablation__bcr_ablation_uuid	ACCB5A02-760D-4F04-8AF4-635EC10BB039
clinical__ablation__days_to_embolization_performed	144
clinical__ablation__embolization_performed_indicator	YES
clinical__ablation__embolization_therapy_drug_name	Doxorubicin
clinical__ablation__embolization_type	Chemoembolization
clinical__ablation__embolizing_agent_utilized	Other, specify
clinical__admin__day_of_dcc_upload	22
clinical__admin__file_uuid	439C6F8F-5B91-4157-827A-6D0F662AAAB2
clinical__admin__month_of_dcc_upload	12
clinical__admin__withdrawn	false
clinical__chol_lihc_shared__albumin_result_lower_limit	3.3
clinical__chol_lihc_shared__albumin_result_specified_value	4.2
clinical__chol_lihc_shared__albumin_result_upper_limit	4.8
clinical__chol_lihc_shared__bilirubin_lower_limit	0
clinical__chol_lihc_shared__bilirubin_upper_limit	0.4
clinical__chol_lihc_shared__child_pugh_classification_grade	A
clinical__chol_lihc_shared__creatinine_lower_level	0.6
clinical__chol_lihc_shared__creatinine_upper_limit	1.4
clinical__chol_lihc_shared__creatinine_value_in_mg_dl	0.8
clinical__chol_lihc_shared__fibrosis_ishak_score	6 - Established Cirrhosis
clinical__chol_lihc_shared__hist_hepato_carc_fact	Alcohol consumption
clinical__chol_lihc_shared__inter_norm_ratio_lower_limit	0.9
clinical__chol_lihc_shared__intern_norm_ratio_upper_limit	1.1
clinical__chol_lihc_shared__platelet_result_lower_limit	150
clinical__chol_lihc_shared__platelet_result_upper_limit	400
clinical__chol_lihc_shared__prothrombin_time_result_value	1
clinical__chol_lihc_shared__specimen_collection_method_name	Lobectomy
clinical__chol_lihc_shared__total_bilirubin_upper_limit	1.4
clinical__chol_lihc_shared__vascular_tumor_cell_type	Macro
clinical__clin_shared__age_at_initial_pathologic_diagnosis	67
clinical__clin_shared__bcr_followup_barcode	TCGA-G3-AAV5-F65955
clinical__clin_shared__bcr_followup_uuid	23C4DFC8-45CA-4E2E-9721-FFC2B8C41D88
clinical__clin_shared__day_of_form_completion	1
clinical__clin_shared__days_to_initial_pathologic_diagnosis	0
clinical__clin_shared__eastern_cancer_oncology_group	1
clinical__clin_shared__informed_consent_verified	YES
clinical__clin_shared__lost_follow_up	NO
clinical__clin_shared__month_of_form_completion	10
clinical__clin_shared__person_neoplasm_cancer_status	WITH TUMOR
clinical__clin_shared__platelet_result_count	326
clinical__clin_shared__post_op_ablation_embolization_tx	NO
clinical__clin_shared__postoperative_rx_tx	YES
clinical__clin_shared__radiation_therapy	YES
clinical__clin_shared__residual_tumor	R0
clinical__clin_shared__tissue_prospective_collection_indicator	YES
clinical__clin_shared__tissue_retrospective_collection_indicator	NO
clinical__clin_shared__tumor_tissue_site	Liver
clinical__clin_shared__viral_hepatitis_serology	Hepatitis  C Antibody
clinical__clin_shared__year_of_form_completion	2014
clinical__clin_shared__year_of_initial_pathologic_diagnosis	2013
clinical__lihc_nte__new_tumor_event_liver_transplant	No
clinical__nte__additional_pharmaceutical_therapy	YES
clinical__nte__additional_radiation_therapy	NO
clinical__nte__days_to_new_tumor_event_after_initial_treatment	117
clinical__nte__new_neoplasm_event_occurrence_anatomic_site	Liver
clinical__nte__new_neoplasm_event_type	Extrahepatic Recurrence
clinical__nte__new_tumor_event_additional_surgery_procedure	NO
clinical__nte__new_tumor_event_after_initial_treatment	YES
clinical__rx__bcr_drug_barcode	TCGA-G3-AAV5-D65944
clinical__rx__bcr_drug_uuid	2DE0F885-BD8A-44B0-88C8-28FC3BA649F3
clinical__rx__clinical_trail_drug_classification	Chemotherapy
clinical__rx__days_to_drug_therapy_start	227
clinical__rx__drug_name	HEC.1 - Sorafenib vs Sorafenib plus Doxorubicin
clinical__rx__therapy_ongoing	YES
clinical__rx__therapy_type	Chemotherapy
clinical__rx__tx_on_clinical_trial	YES
clinical__shared__histological_type	Hepatocellular Carcinoma
clinical__shared__history_of_neoadjuvant_treatment	No
clinical__shared__neoplasm_histologic_grade	G2
clinical__shared__other_dx	No
clinical__shared_stage__pathologic_m	M0
clinical__shared_stage__pathologic_n	N0
clinical__shared_stage__pathologic_t	T2
clinical__shared_stage__system_version	7th
gdc__access	open
gdc__acl	open
gdc__aliquots__aliquot_id	e155a2ba-8842-417b-ab5a-e49339136236
gdc__aliquots__concentration	0.18
gdc__aliquots__source_center	23
gdc__aliquots__submitter_id	TCGA-G3-AAV5-01A-11R-A37K-07
gdc__aliquots__updated_datetime	2018-09-06T14:13:07.098771-05:00
gdc__analysis__analysis_id	97c55f64-7e24-46e1-be10-163e1028480b,4068f307-0f73-4e9a-ac25-91b4cd2d5a4f,eb66ba00-8bec-4ea5-8590-b274a09ab0e2
gdc__analysis__workflow_link	https://github.com/NCI-GDC/htseq-cwl
gdc__analysis__workflow_type	HTSeq - Counts,HTSeq - FPKM,HTSeq - FPKM-UQ
gdc__analysis__workflow_version	v1
gdc__analytes__a260_a280_ratio	1.96
gdc__analytes__analyte_id	77d84cb2-614b-47c1-97bb-0871b0b0b8e4
gdc__analytes__analyte_type	RNA
gdc__analytes__analyte_type_id	R
gdc__analytes__spectrophotometer_method	UV Spec
gdc__case_id	4dff4242-4a53-4f46-b200-7ed83f6b7808
gdc__center__center_id	ee7a85b3-8177-5d60-a10c-51180eb9009c
gdc__center__center_type	CGCC
gdc__center__code	07
gdc__center__name	University of North Carolina
gdc__center__namespace	unc.edu
gdc__center__short_name	UNC
gdc__created_datetime	2016-05-29T10:26:12.649807-05:00,2016-05-29T10:26:12.984653-05:00,2016-05-29T10:26:12.816456-05:00
gdc__data_category	Transcriptome Profiling
gdc__data_format	TXT
gdc__data_type	Gene Expression Quantification
gdc__demographic__demographic_id	323b80c1-1c08-54cc-ac04-c6573bf86f5c
gdc__demographic__ethnicity	not hispanic or latino
gdc__demographic__gender	male
gdc__demographic__race	white
gdc__demographic__year_of_birth	1946
gdc__diagnoses__age_at_diagnosis	24655
gdc__diagnoses__classification_of_tumor	not reported
gdc__diagnoses__days_to_birth	-24655.0
gdc__diagnoses__days_to_last_follow_up	354.0
gdc__diagnoses__diagnosis_id	ad068150-55ad-5a92-8d7d-231e1400cdfc
gdc__diagnoses__last_known_disease_status	not reported
gdc__diagnoses__morphology	8170/3
gdc__diagnoses__primary_diagnosis	Hepatocellular carcinoma NOS
gdc__diagnoses__prior_malignancy	not reported
gdc__diagnoses__progression_or_recurrence	not reported
gdc__diagnoses__site_of_resection_or_biopsy	Liver
gdc__diagnoses__tissue_or_organ_of_origin	Liver
gdc__diagnoses__tumor_grade	not reported
gdc__diagnoses__tumor_stage	stage ii
gdc__diagnoses__vital_status	alive
gdc__disease_type	Adenomas and Adenocarcinomas
gdc__experimental_strategy	RNA-Seq
gdc__exposures__bmi	32.32323232323232
gdc__exposures__exposure_id	f1d179b1-8ce8-5d5c-81e0-48487db25982
gdc__exposures__height	165.0
gdc__exposures__weight	88.0
gdc__file_id	9a8560b6-f42f-44ed-b579-2bdfd25643c8,730548e5-e36d-4c83-a3f3-54695f5c197d,ef0392b6-a83f-4ca8-92b0-ef62e24a1c23
gdc__file_name	e4d48564-e021-4bbc-bc00-145e9d64b501.htseq.counts.gz,e4d48564-e021-4bbc-bc00-145e9d64b501.FPKM.txt.gz,e4d48564-e021-4bbc-bc00-145e9d64b501.FPKM-UQ.txt.gz
gdc__file_size	248067,493623,494654
gdc__input_files__data_category	Raw Sequencing Data
gdc__input_files__data_format	BAM
gdc__input_files__data_type	Aligned Reads
gdc__input_files__experimental_strategy	RNA-Seq
gdc__input_files__platform	Illumina
gdc__md5sum	baa3dd6a7684a4fe557283ff1a65d42c,05e3395a2632e21c98274c8f57532684,d47b43a432e92f6de0f0886be55191bd
gdc__portions__is_ffpe	false
gdc__portions__portion_id	97a6b448-a69d-48f0-b634-1900676b60ef
gdc__portions__portion_number	11
gdc__portions__weight	30.0
gdc__primary_site	Liver and intrahepatic bile ducts
gdc__program__dbgap_accession_number	phs000178
gdc__program__name	TCGA
gdc__program__program_id	b80aa962-9650-5110-b3eb-bd087da808db
gdc__project__disease_type	Liver Hepatocellular Carcinoma
gdc__project__primary_site	Liver
gdc__project__project_id	TCGA-LIHC
gdc__project__releasable	false
gdc__project__released	true
gdc__samples__days_to_collection	62
gdc__samples__initial_weight	450.0
gdc__samples__oct_embedded	true
gdc__samples__pathology_report_uuid	A578503A-47F1-4DD4-B3E8-C1642EF89190
gdc__samples__sample_id	4e8b5c38-4e61-4f34-9255-da81ff5db4b7
gdc__samples__sample_type	Primary Tumor
gdc__samples__sample_type_id	01
gdc__slides__percent_lymphocyte_infiltration	2.0
gdc__slides__percent_monocyte_infiltration	0.0
gdc__slides__percent_necrosis	0.0
gdc__slides__percent_neutrophil_infiltration	0.0
gdc__slides__percent_normal_cells	0.0
gdc__slides__percent_stromal_cells	0.0
gdc__slides__percent_tumor_cells	100.0
gdc__slides__percent_tumor_nuclei	80.0
gdc__slides__section_location	TOP
gdc__slides__slide_id	a7f23986-d411-4f01-96f8-3301f4635a09
gdc__submitter_id	e4d48564-e021-4bbc-bc00-145e9d64b501_count,e4d48564-e021-4bbc-bc00-145e9d64b501_fpkm,e4d48564-e021-4bbc-bc00-145e9d64b501_uqfpkm
gdc__tissue_source_site__bcr_id	NCH
gdc__tissue_source_site__code	G3
gdc__tissue_source_site__name	Alberta Health Services
gdc__tissue_source_site__tissue_source_site_id	addd7b04-91a3-5179-99a5-cbff20df6bb4
gdc__treatments__treatment_id	73ecec3b-43ca-5cf5-896b-0bd7be0b58e5
gdc__type	gene_expression
gdc__updated_datetime	2018-09-08T13:43:34.032262+00:00
manually_curated__data_format	BED
manually_curated__download_date	2018-11-06T08:11:23.370+01:00
manually_curated__exp_data_bed_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/gene_expression_quantification/e155a2ba-8842-417b-ab5a-e49339136236-geq.bed
manually_curated__exp_metadata_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/gene_expression_quantification/e155a2ba-8842-417b-ab5a-e49339136236-geq.bed.meta
manually_curated__genome_built	GRCh38
manually_curated__local_file_size	5059972
manually_curated__local_md5	1489816bf102bb82e21a0ba057b803ed
manually_curated__opengdc_download_date	2018-10-15T16:24:02.000229+02:00
manually_curated__opengdc_file_md5	4522c9bc38ba48d6558b416256d79191
manually_curated__opengdc_file_size	1652727
manually_curated__opengdc_id	e155a2ba-8842-417b-ab5a-e49339136236-geq
manually_curated__origin_file_size	5059972
manually_curated__origin_last_modified_date	Mon Oct 15 16:41:00 CEST 2018
manually_curated__origin_md5	1489816bf102bb82e21a0ba057b803ed
manually_curated__tissue_status	tumoral
num	60483
